Results 191 to 200 of about 564,115 (361)
Role of the modifications at the interface in glass fiber reinforced composites for damage monitoring. ABSTRACT Glass Fiber Reinforced Polymers (GFRPs) are widely used in structural applications but degrade over time due to internal damage. Structural Health Monitoring (SHM) enables early damage detection, improving reliability and reducing maintenance
Marta Colombo +10 more
wiley +1 more source
A Hybrid Low-Complexity WMMSE Precoder with Adaptive Damping for Massive Multi-User Multiple-Input Multiple- Output Systems. [PDF]
Sen V, Deng H, Xu X, Shen M.
europepmc +1 more source
Heterogeneous biaxial testing for anisotropic elastic properties identification from full displacement field. ABSTRACT The stretch‐blowing process of PET bottles induces significant anisotropy in mechanical properties due to the differential elongation of macromolecular chains.
Thanh Tung Nguyen +3 more
wiley +1 more source
First Order Expansion in the Semiclassical Limit of the Levy-Lieb Functional. [PDF]
Colombo M, Di Marino S, Stra F.
europepmc +1 more source
On the Hermite Positive Definite Solution of the Matrix Equation X + A∗ (Im⊗X-C)-tA=Q
Feng Yan, Luping Xu, Minghui Wang
openalex +1 more source
ABSTRACT N‐vinylamides, especially noncyclic N‐vinylacetamide (NVA), have been used in various applications such as biomaterials, surfactants, and hydrogels. However, their potential to copolymerize with cyclic ketene acetal (CKA) to create degradable polymers is underexplored.
Mukmin Sapto Pamungkas +2 more
wiley +1 more source
Thermodynamic Theory of Macrosystems: Entropy Production as a Metric. [PDF]
Amelkin S.
europepmc +1 more source
Computation of the Newton step for the even and odd characteristic polynomials of a symmetric positive definite Toeplitz matrix [PDF]
A. Melman
openalex +1 more source
ABSTRACT Long‐acting injectable medicinal products (LAIs) prolong drug release and thereby aim to enhance adherence and patient outcomes. European regulatory guidelines require the conduct of single‐ and multiple‐dose trials to exclude differences in drug release between non‐steady and steady state conditions. The complexity of these trials may however
D. Esther Lubberts +4 more
wiley +1 more source

